Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.12 USD | +2.09% | +4.13% | +50.46% |
04-29 | Fitch Maintains CRH's Ratings on Strong Business Profile, Operating Performance | MT |
04-25 | UK-listed drugmaker Indivior seeks shareholder nod for US listing | RE |
Sales 2024 * | 34.09B 36.69B 50.2B | Sales 2025 * | 35.85B 38.58B 52.78B | Capitalization | 52.07B 56.04B 76.67B |
---|---|---|---|---|---|
Net income 2024 * | 3.42B 3.68B 5.04B | Net income 2025 * | 3.36B 3.62B 4.95B | EV / Sales 2024 * | 1.69 x |
Net Debt 2024 * | 5.42B 5.83B 7.97B | Net Debt 2025 * | 4.14B 4.46B 6.1B | EV / Sales 2025 * | 1.57 x |
P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
14.4
x | Employees | 78,500 |
Yield 2024 * |
1.74% | Yield 2025 * |
1.84% | Free-Float | 93.61% |
Latest transcript on CRH plc
1 day | +2.09% | ||
Current month | +50.46% | ||
Current year | +50.46% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Manifold
CEO | Chief Executive Officer | 61 | 97-12-31 |
Jim Mintern
DFI | Director of Finance/CFO | 57 | 21-05-31 |
Randy Lake
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Fearon
BRD | Director/Board Member | 68 | 20-12-02 |
Johan Karlström
BRD | Director/Board Member | 67 | 19-09-24 |
Siobhán Talbot
BRD | Director/Board Member | 60 | 18-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 82.12 | +2.09% | 1,916,031 |
24-05-03 | 80.44 | +1.12% | 2,535,534 |
24-05-02 | 79.55 | +3.11% | 2,727,149 |
24-05-01 | 77.15 | -0.35% | 2,530,108 |
24-04-30 | 77.42 | -1.83% | 2,886,999 |
Delayed Quote Nyse, May 06, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.22% | 36.97B | |
-7.50% | 33.76B | |
+14.98% | 19.94B | |
+20.39% | 19.12B | |
+15.90% | 17.88B | |
+1.36% | 11.49B | |
+4.81% | 7.07B | |
+22.05% | 4.57B | |
+14.82% | 3.94B |
- Stock Market
- Equities
- CRH Stock
- CRH Stock